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Introduction: The opioid epidemic has been largely attributed to changes in prescribing 
practices over the past 20 years. Although current overdose trends appear driven by the opioid 
fentanyl, heroin has remained the focus of overdose fatality assessments. We obtained full 
toxicology screens on lethal overdose cases in a major US city, allowing more accurate 
assessment of the time-course of fentanyl-related deaths. 
Methods: We used coroner data from Marion County, Indiana comprising 1583 overdose deaths 
recorded between January 1, 2010 and April 30, 2017. Bayesian multilevel models were fitted to 
predict likelihood of lethal fentanyl-related overdose using information about the victim's age, 
race, sex, zip code, and date of death. 
Results: Three hundred and seventy-seven (23.8%) overdose deaths contained fentanyl across 
the seven-year period. Rates rose exponentially over time, beginning well below 15% from 2010 
through 2013 before rising to approximately 50% by 2017. At the beginning of the study period, 
rates of fentanyl overdose were lowest among Black persons but increased more rapidly, 
eventually surpassing Whites. Currently, White females may be at particularly low risk of 
fentanyl overdose and Black females at high risk. Rates were highest for younger and middle-
aged groups. Over time, fentanyl was more likely detected without the presence of other opioids.  
Conclusions: Fentanyl has increasingly been detected in fatal overdose deaths in Marion 
County. Policy and program responses must focus on education for those at highest risk of 





The United States is experiencing a massive increase in the rate of fatal opioid1 overdose, 
with deaths having quadrupled over the past 16 years (Rudd, 2016). This trend is largely 
attributed to the sharp increase in opioid prescribing that occurred over the past two decades 
(Alpert, Powell, & Pacula, 2017; Banta-Green, Beletsky, Schoeppe, Coffin, & Kuszler, 2013; 
CDC, 2011; Dart, Surratt, Cicero, Parrino, Severtson et al., 2015), and much of the public health 
response to this crisis has been aimed at curbing problematic prescribing (Wickramatilake, Zur, 
Mulvaney-Day, Klimo, Selmi et al., 2017). However, to a large extent, the recent rise in 
overdose deaths is the result of illicit opioids (Rudd, Paulozzi, Bauer, Burleson, Carloson et al., 
2014; Rudd, 2016), and research suggests that this increase has been exacerbated by the 
dwindling availability of their prescriptions counterparts (Cicero, Ellis, Surratt, & Kurtz, 2014; 
Cerdá, Santaella, Marshall, Kim, & Martins, 2015; Mars, Bourgois, Karandinos, Montero, & 
Cicarone, 2014; Ray, Quinet, Dickenson, Watson, & Ballew, 2017).  
 Previous research demonstrates heroin overdose death rates have more than tripled from 
2010 to 2014 (Rudd, 2016), but what is often less addressed in the literature are deaths associated 
with fentanyl. The additional arrival of fentanyl—a synthetic opioid 50 times more potent than 
heroin (National Center for Injury Prevention and Control 2016)—within the U.S. illicit drug 
market has further increased the risk of fatal opioid overdose (Ray et al., 2017; Frank & Pollack, 
2017). Despite fentanyl’s prevalence in the illicit drug market, heroin has remained the focus of 
overdose fatality assessments. This is because the International Classification of Diseases (ICD), 
the standard diagnostic tool used by the Centers for Disease Control and Prevention (CDC) to 
examine mortality trends, codes fentanyl and many other loosely related drugs together under the 
same umbrella category "synthetic opioids" (T40.4), with no unique diagnostic code for fentanyl 
specifically (Wysowski, 2007; Fernandez et al., 2016; Ossiander, 2014). For example, from 2014 
to 2015 heroin death rates increased by 20.6%, yet deaths from synthetic opioids increased by 
72.2%. The CDC notes this increase is most likely attributable to illicitly manufactured fentanyl; 
however, ICD codes are not able to assess trends by a specific substance. This is problematic, as 
policy and program responses to the opioid epidemic require accurate information regarding the 
drugs driving overdose trends to maximize their effectiveness.  
In an effort to better examine trends in fentanyl overdose some researchers have looked 
directly at the medical examiner and coroner data (see Somerville, O’Donnell, Gladden, Zibbell, 
Green et al., 2017; Warner, Trinidad, Bastian, Minino, & Hedegaard, 2016), and others have 
used computer software to code the actual text written by the certifier (Ossiander, 2014); 
however, analyzing the text of the certifier can be challenging when there are multiple opioid 
substances detected. Another method for examining the presence of fentanyl is to look at the 
results from the toxicology analysis. In using toxicology data, researchers are not assessing 
fentanyl as a “cause of death” but rather as a substance detected as part of a drug overdose 
investigation. The present study uses this latter method by examining data from toxicology 
reports to assess trends in the presence of fentanyl in drug overdoses in Marion County, Indiana, 
from January 1, 2010, through April 30, 2017. In doing so, we document the dramatic increases 
in fentanyl-related deaths, examine sociodemographic characteristics among these fatalities, and 
also explore polydrug combinations. We use Bayesian models to examine trends in rates of a 
positive fentanyl toxicology screen among people who lethally overdosed and provide estimates 
of the course of the epidemic. 
                                                              
1   In this paper we use “opioid” to refer to the entire family of natural, synthetic, and semi-synthetic opiates. 
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2. Materials and Methods  
The data used in this study come from the Marion County Coroner’s Office. This Office 
serves Marion County, which is the largest county in Indiana (2015 population estimated at 
939,020) and the location of the state capitol of Indianapolis. The Marion County Coroner’s 
Office has jurisdiction over all drug overdose fatalities within the county, and, as part of an 
ongoing collaboration with Indiana University researchers, maintains a database with 
information from death certificates and toxicology reports on all drug overdose fatalities. The 
data used in this study consist of every lethal overdose reported by the coroner’s office from 
January 1, 2010, through April 30, 2017, and consist of 1,698 cases. Of these, 107 cases were 
dropped because the overdose occurred outside of Marion County, four cases were dropped 
because the place of overdose was unknown, and four cases were dropped because the person 
was a child under 5 years of age (the next youngest death was 16 years old), for a final sample of 
1,583 individuals. We captured sociodemographic variables such as age, race/ethnicity, and 
gender from the death certificates and the presence of opioids from toxicology reports. For the 
toxicology report there is a detection threshold established by the testing agency and when a 
substance exceeds that threshold it is included in the toxicology report and coded into the 
database. The opioids we were able to consistently code for during this time period included 
fentanyl (with analogues such as norfentanyl, acetylfentanyl), 6-monoacetylmorphine (heroin), 
morphine, codeine, oxycodone, hydrocodone, oxymorphone, and hydromorphone. It should be 
noted that one of the limitations of using toxicology data is the inability to accurately determine 
morphine and codeine. Specifically, because some illicit manufactured opioids, such as heroin, 
undergo a rapid transformation into natural opioids of morphine and codeine (Avella, Katz, & 
Lehrer, 2007), we follow previous work looking at polydrug interactions (Harruff, Couper, & 
Banta-Green, 2015) and did not include morphine or codeine though did include these substances 
in our overall detection of opioids.  
 
2.1. Analytic Approach 
Our analysis begins by looking at raw numbers of drug overdoses over time and the 
presence of fentanyl among these cases; however, our primary goal is to build a statistical model 
of changes over time in the probability of a positive fentanyl toxicology screen among people 
who lethally overdose. This allows for a more complete demographic picture of the epidemic and 
estimates of its course over time. All data preparation and analysis were performed using R and 
the Stan probabilistic programming software, which allowed us to fit fully Bayesian models and 
specify priors (R package rethinking v 1.59). Lethal overdoses are modeled using the following 
information: location of overdose by zip code, exact date of death, age at death, and race/gender 
categories. We guard against overfitting in three ways: (1) by using weakly informative priors on 
all parameters (e.g., Normal [0,5] on the slope parameter for z-scored date of death, suggesting 
mild skepticism that any two-year interval would see rates of positive Fentanyl toxicology 
screens move from <.001% to >99.99% of all lethal overdoses); (2) by using graphical checks 
and WAIC estimates to guide the decision of whether to include a given covariate in the final 
model (Watanabe, 2010); and (3) by fitting hierarchical models for relevant parameters to 
partially pool estimates toward the population mean where appropriate, such as for subgroups 
with small numbers of observations.  
The relationship between date of death and rate of positive fentanyl toxicology screen 
was modeled using linear, quadratic and cubic parameters. Higher-order polynomials did not 
improve WAIC scores and so were not included in the final model. Age at death was entered into 
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the model with linear and quadratic parameters (higher-order polynomials did not improve fit). 
Ethnicity (Black, White, or Other) and sex (Male, Female) combinations were introduced as 
varying intercepts (J=1,2,…,6) to allow partial pooling to constrain estimates for groups with 
small numbers (e.g., only 5 people were categorized as Other Female). Zip code was introduced 
into the model as a varying intercept as well, which improved fit and suggested that there may be 
geographic “hot” and “cool” spots that cannot be better accounted for by measured demographic 
patterns in lethal overdoses. 
To allow for the possibility that different groups have experienced different trajectories in 
rates of lethal fentanyl-related overdose over time, we varied the slope parameters for date of 
death by each gender/ethnicity combination, improving model fit considerably as estimated by 
WAIC and graphical checks. We also included an interaction term between age and date of 
death, as risk of fentanyl-related overdose appears to have increased at slightly faster rates for 
younger than for older people. Varying time slopes by zip code yielded worse WAIC scores and 
were therefore not included in the final model, suggesting little evidence that different zip codes 
have experienced different trajectories in rates of fentanyl-related overdose over time. Code for 
data preparation, model fitting, and figures are included as a supplement. 
Our use of multilevel modeling also allows for the inclusion of covariates at the zip code-
level. Therefore, we included the following geographic covariates with data derived from the 
U.S. Census: median household income for each zip code, percent in poverty, percent urban, and 
percent of residents holding a bachelors degree or higher. However, none of these variables 
showed substantive predictive power (for all coefficient estimates, 75% credible intervals 
included zero). Therefore, we did not include these predictors in our final models. 
 
3. Results 
We analyzed 1,583 overdoses occurring in Marion county during the study period 
(January 1, 2010 through April 30, 2017), with ages at death ranging from 16 years to 77 years 
old. Of these, 377 (23.8%) contained fentanyl. The average age of the total drug overdose 
population was 40.2 years; 64.1% were male; and 81.1% were coded as White, 17.3% Black, 1% 
Hispanic/Latino, and 1.3% were unknown or other (given the small group size, we analyzed 
ethnic groups as White, Black, or Other). Compared with the overall sample of lethal drug 
overdoses, the sociodemographic characteristics of those who died while testing positive for 
fentanyl suggest they were on average more likely to be younger (37.6 years) and more likely to 
be male (66.8%) and Black (20.4%).  
 
 [Figure 1a and 1b about here] 
 
Figure 1a illustrates the number of drug overdose deaths during the study period (with 
2017 representing January 1, 2017 through April 30, 2017) with lines representing the percent of 
deaths where any opioid was present and the percent of deaths where fentanyl was present. The 
number of drug related overdose deaths has increased in Marion County during the study period, 
from 121 in 2010 to 325 in 2016. The percent of overdose deaths containing any of the opioids 
coded for in this study (i.e. fentanyl, 6-monoacetylmorphine, morphine, codeine, oxycodone, 
hydrocodone, oxymorphone, and hydromorphone) also increased from 64.5% in 2010 to 81.2% 
in 2016. Similarly, the detection of fentanyl has shown dramatic increases. In 2014 the presence 
of fentanyl in drug overdose deaths increased nearly five-fold from 7% in 2013 to 29% in 2014. 
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In 2016 fentanyl was detected in 44.9% of all drug overdose and so far in 2017 has been detected 
in 44.7% of cases, outstripping heroin (37.4%).  
We also looked at polydrug interactions with fentanyl and other opioids for which data 
were available (heroin, oxycodone, hydrocodone, oxymorphone, and hydromorphone). In 2010 
and 2011 there were no cases of fentanyl mixed with heroin; however, in 2010 oxycodone, 
hydromorphone, and oxymorphone occurred in 40% of fentanyl detections and hydrocodone in 
27% of cases. By 2013 heroin was detected in 29% of fentanyl cases and peaked in 2015 with 
detections in 32% of fentanyl cases. As shown in Figure 1b, fentanyl is increasingly being 
detected with heroin while decreasingly being detected with prescription opioids. However, it is 
also important to note that fentanyl is often detected alone; that is, without other opioids. As 
illustrated in Figure 1b, the proportion has fluctuated during the study period, yet when we 
consider that in 2010 there were only 15 fentanyl detections, with 33% (n=5) detected alone, and 
in 2016 there were 146 detections with 47% (n=68) detected alone, it is clear that much of the 
recent spike in fentanyl-related deaths are associated with fentanyl alone.  
 
3.1. Model Estimates 
Next we turn to our Bayesian model of changes over time in the probability of a positive 
fentanyl toxicology screen among people who lethally overdose. Figure 2 shows the trajectory 
over time for the city as a whole, with one thousand regression lines sampled from the posterior 
distribution to display uncertainty in the regression relationship between time and lethal fentanyl-
related overdose rates. Fentanyl-related deaths were very rare (mostly <10%) until mid-2014 
when the county began to see exponential increases. In 2017, for the first time, rates of fentanyl-
related overdose are likely to break 50%, far higher than other common drugs such as heroin. 
 
[Figure 2 about here] 
 
Figure 3 shows Bayesian estimates across the lifespan, broken down by race/ethnicity, 
sex, and time, with dark lines indicating risk of fentanyl-related overdose for these demographic 
categories at different ages. Grey shaded regions give 95% credible intervals for these estimates, 
widened via model-based simulation to account for variation due to geography.  
Rates of lethal fentanyl-related overdose appear to be highest for young and middle-aged 
people, with a steep drop-off around age 50-60. Although the model allowed for the possibility 
that time trajectories would differ by race, sex, and age (e.g., model estimates show rates for 
younger people increasing slightly more quickly than rates for older people), our estimates 
suggest that all groups experienced exponential increases in fentanyl-related overdose over time 
with particularly large spikes in 2014-2015.  
 
[Figure 3 about here] 
 
There were important differences in trajectories by demographic groups. Relative to 
Whites, Blacks began the decade with very low rates of fentanyl-related overdose; however, risk 
of fentanyl-related overdose increased more rapidly among Blacks in the past 2-3 years and is 
now higher than the risk for Whites. For example, in January 2011, Blacks had an estimated 3% 
rate of fentanyl-related overdose as compared to 9% rates for Whites. By 2017 that pattern had 
reversed dramatically, with Blacks at 61% risk versus 46% for Whites.  
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Our model suggests White Females may be at particularly low risk and Black Females at 
particularly high risk. Sampling from the posterior allows us to assign a probability to these 
comparisons between demographic groups and gives us a sense of the uncertainty in our 
estimates. As of January 2017, the average White female had an estimated 40% rate of fentanyl-
related overdose—there was a 98% probability that their true rates were lower than Black 
Females, a 99% probability that they were lower than Black Males, and a 94% probability that 
they were lower than White Males. The average Black female, on the contrary, had estimated 
rates of 62%, putting them at higher risk than White Females (98% probability) and White Males 
(89% probability). Although rates for Black Females were also higher than the 59% rates we 
estimate for Black Males in the same month, uncertainty in the credible intervals for these 
subgroups is relatively large and the probability that true rates for Black Females were higher 
than rates for Black Males is only 60%.  
Zip code of lethal overdose also provided some information about risk of fentanyl-related 
overdose unaccounted for by the other information we had available. Figure 4 shows a map of 
the relative risk of fentanyl-related overdose by zip code after accounting for time and 
demographic variables. As shown, risk varies substantially by geography, with some zip codes 
yielding about 8% greater risk of fentanyl-related overdose assuming all other factors are held 
constant (e.g., race, age). This suggests the possibility of geographic “hot” and “cool” spots with 
respect to fentanyl. This could have purely spatial causes (e.g., a particularly potent batch of 
fentanyl is distributed by someone dealing within a specific neighborhood), or could be due to 
latent variables we did not measure such as neighborhood disorder (Epstein et al., 2014) or 
relative neighborhood disadvantage experienced by overdose victims (see Mennis et al., 2016), 
or all of the above. We further explored this using available data from the U.S. Census and tested 
for effects of median household income, percent of the zip code residents in poverty, percent 
holding a bachelors degree or higher, and percent urban. However, none of these measures were 
significant predictors.  
 
[Figure 4 about here] 
 
4. Discussion 
The present study used toxicology and death certificate data from the Marion County 
(Indianapolis) Coroner’s Office to examine changes in fentanyl-related overdoses from January 
1, 2010, through April 2017. Our analysis assessed changes in the detection of fentanyl alongside 
other opioids in overdose deaths and also provided us with sociodemographic and geographic 
measures that we used in multilevel Bayesian models to estimate past and present trends in 
fentanyl-related overdose. Our findings suggest drug overdoses have continued to increase since 
2010 and opioids are consistently detected among the majority of these deaths. However, 
fentanyl has increasingly been detected in fatal drug overdose deaths since 2014 and now 
comprises nearly half of all lethal overdose deaths. We also explored polydrug interactions in an 
effort to better understand what fentanyl is being mixed with. This analysis illustrates that, 
during the study period, fentanyl is decreasingly being detected alongside prescription opioids 
and is increasingly detected with heroin, but more often fentanyl-related deaths are from fentanyl 
alone. Finally, our model suggests different demographic groups have experienced distinctive 
trajectories in fentanyl-related overdoses. Specifically, risk of fentanyl-related overdose has risen 
more rapidly for Blacks than for Whites, with Blacks beginning the decade with the lowest rates 
of fentanyl-related overdose but ending the study period with higher rates than Whites. White 
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females may now be at particularly low risk and Black females at particularly high risk. In the 
media the opioid epidemic has largely been framed as a White problem. Our findings suggest 
that, in Indianapolis at least, this may have been partially true in the past but is no longer the 
case.  
By using toxicology data instead of ICD codes we were better able to detect changes in 
specific substances and more accurately determine when fentanyl entered the illicit drug market 
in Marion County, providing convergent evidence with national studies that show illicit opioids, 
particularly fentanyl, are driving the increases in fatal drug overdose (Rudd, 2016; Rudd et al., 
2014). Our findings also add substantially to understandings of racial differences in the opioid 
epidemic. Prior research has documented that prescription rates of opioids are lower among 
Blacks compared to Whites (Meghani, Byun, & Gallagher, 2012). It is possible that Black people 
were more likely than Whites to encounter fentanyl as the drug entered the illicit market in the 
middle of the decade. Unlike earlier authors who theorized that differences in mortality were the 
result of differential use behaviors by race (see Chen et al. 2005; McCabe et al. 2005; and 
Meghani et al., 2012), recent mixed-methods studies with active opioid users (Macmadu et al., 
2017; Carroll et al., 2017) suggest exposure to fentanyl is largely driven by product supply. It is 
also important to note that these studies and others (see Hempstead & Yildirim, 2014; Amlani et 
al., 2015) show opioid users prefer to avoid fentanyl for fear of unpredicted effects. Thus, our 
findings regarding race might suggest changes in overall product supplies (e.g., fentanyl rather 
than heroin), increased availability, or potentially that there are other socioeconomic factors 
contributing to fatal rather non-fatal overdose among disadvantaged populations.  
It is worth highlighting some strengths and weaknesses of the current paper. The use of 
multilevel Bayesian models has substantial advantages over classical methods. Uncertainty is 
clearly displayed in our estimates, with wider credible intervals for groups and time points for 
which we have less information, such as very young ages and very late time points. Partial 
pooling is also clearly visible, with estimates for groups with few observations pulled toward the 
population mean. This represents a mathematically rigorous compromise between overfitting to 
small groups and under-fitting by ignoring observed variation. For example, varying intercepts 
and slopes for all race/sex subgroups allowed estimates for the Other Female category to follow 
a distinct but not wild trajectory, appropriate given the small number of observations in this 
group (n=5, see Figure 3). Finally, estimating population distributions for groups allows us to 
simulate unobserved data. For example, risk of fentanyl-related overdose in three zip codes with 
no observations were simulated for Figure 4 using the model’s estimated variation between zip 
codes. Point estimates for these zip codes will appear “average” but the simulation allows us to 
add a measure of uncertainty to these point estimates (see Gelman & Hill, 2007). 
There were significant limitations to this study. Data were only available for a single 
Midwestern geographic area and may not be generalizable to other urban or rural areas in the 
United States. Similarly, this study was constrained by our reliance on multiple sources of 
administrative data and we were limited in the years for which electronic death certificates were 
available as well as the substances that we could reliably code for over this period. For example, 
we were unable to reliably code for methadone or benzodiazepines for this time period. 
Moreover, we are not able to further disentangle the contributing factors to these deaths to better 
assess other elements that might explain our findings. Finally, our use of zip code as the level of 
geographic analysis has drawbacks, as zip codes are not clearly theoretically meaningful units. 
The results of the current study indicate that rates of fentanyl-related overdose do depend on 
location in Indianapolis; however, even after exploring household income, percent in poverty, 
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percent urban, and percent holding a bachelors degree or higher, we were still unable to answer 
the question of why which limits the generalizability of the study and calls for further research.  
Given our findings and those from extant research, the policy implications of increased 
fentanyl-related deaths suggest a need to better educate potential fentanyl users so they 
understand how to protect themselves and people who they use with from exposure and 
overdose. This education should focus on the potential for fatal overdose from fentanyl when 
using illicit opioids, the use of test kits to enable users to detect fentanyl, and the benefits of both 
agonist and antagonist medication assisted treatment. Finally, our demographic findings indicate 
the need for culturally appropriate education efforts that take into consideration the unique 
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Figure 1a. Detection of opioids and fentanyl among drug overdose deaths. Note that the bars and 
lines are on different scales, with bars giving all-cause overdose counts and lines giving the 











Figure 2. City-wide estimates for lethal overdoses over time. Observed data are plotted as 
vertically jittered points. Model-based estimates are shown as one thousand regression lines 
sampled from the posterior distribution to display uncertainty in the regression relationship 
between time and lethal overdose. The vertical dotted line marks April 2014. 
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Figure 3. Rates of positive fentanyl toxicology screens at overdose by age at death, race, sex, and time. Observed data are plotted as vertically 
jittered points with lines giving model-based estimates (solid) and 95% credible intervals (shaded) halfway through each plotted 2-year 
interval. Residual error due to geography was added to model estimates by simulating zip code-level variation from model parameters. In 
2014, all demographic groups experienced dramatic increases in rates of lethal fentanyl-related overdose. Prior to 2014, black people were at 
particularly low risk of lethal fentanyl-related overdose. However, they experienced relatively fast rate increases and by 2017 their risk had 
surpassed that of white people. 
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Figure 4. Risk of lethal Fentanyl-related overdose attributable to zip code of overdose, after 
accounting for date of death, age at death, race, and sex.  
 
 
 
 
